Delivery Order SPE2DB22D3004-SPE2DB25FQQ29
Award Date
5/8/25
Potential Completion Date
5/9/25
Potential Value
$2.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Gadavist, a pharmaceutical product used for medical imaging, with a ceiling value of $2,051.44 and a period of performance through April 29, 2025. This contract is not set aside and was awarded through open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,834.97 firm fixed-price delivery order is for Gadavist 10 mmol/10 ml vials. The contract has an ultimate completion date of November 27, 2024 and was awarded on November 26, 2024. This award is a part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,608.22 firm fixed price delivery order is for the supply of Gadavist, a medical imaging agent, with a completion date of May 30, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
The U.S. Defense Logistics Agency (DLA) awarded a $1,180.34 firm fixed-price delivery order to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide Gadavist 1 mmol/ml bulk vials. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for the company to supply a comprehensive range of pharmaceutical products and medical supplies to support...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,501.90 firm fixed-price contract provides Gadavist, a 10 ml vial of a 10 mmol/ml contrast agent, with a period of performance through February 6, 2025. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract...
The federal contract award is for the delivery of Gadavist (10 mL syringes) to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,159.59 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 28, 2024. The contract has an ultimate completion date of October 29, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,846.18 firm fixed price delivery order is for the supply of 30 mL bulk vials of the medication Gadavist, a contrast agent used in medical imaging. The contract has a period of performance through March 18, 2025 and was not designated with a set-aside requirement. Amerisourcebergen holds a larger $999,999,999 Indefinite...
This federal contract award, valued at $1,942.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,164.96 firm fixed price delivery order is for the supply of the pharmaceutical product Gadavist 7.5 mmol/7.5 ml vial, with an ultimate completion date of April 10, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025....
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,009.10, is for the delivery of Gadavist, a medication used in magnetic resonance imaging (MRI) procedures. The contract is a firm fixed-price delivery order and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with...